Sara Ricardo
Sara Ricardo
Verified email at
Cited by
Cited by
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
S Ricardo, AF Vieira, R Gerhard, D Leitão, R Pinto, JF Cameselle-Teijeiro, ...
Journal of clinical pathology 64 (11), 937-946, 2011
Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44
C Pinheiro, RM Reis, S Ricardo, A Longatto-Filho, F Schmitt, F Baltazar
Journal of Biomedicine and Biotechnology 2010, 2010
p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin
JS Reis-Filho, A Preto, P Soares, S Ricardo, J Cameselle-Teijeiro, ...
Modern Pathology 16 (1), 43-48, 2003
Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
A Albergaria, S Ricardo, F Milanezi, V Carneiro, I Amendoeira, D Vieira, ...
BMC cancer 11 (1), 1-10, 2011
P‐cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal‐like breast cancer
AF Vieira, S Ricardo, MP Ablett, MR Dionísio, N Mendes, A Albergaria, ...
Stem cells 30 (5), 854-864, 2012
P‐cadherin functional role is dependent on E‐cadherin cellular context: a proof of concept using the breast cancer model
AS Ribeiro, B Sousa, L Carreto, N Mendes, AR Nobre, S Ricardo, ...
The Journal of pathology 229 (5), 705-718, 2013
HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas
SAV Ricardo, F Milanezi, ST Carvalho, DRA Leitão, FCL Schmitt
Journal of clinical pathology 60 (9), 1001-1005, 2007
Estimation of hormone receptor status in fine‐needle aspirates and paraffin‐embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2
G Cano, F Milanezi, D Leitão, S Ricardo, MJ Brito, FC Schmitt
Diagnostic cytopathology 29 (4), 207-211, 2003
Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas
R Gerhard, S Ricardo, A Albergaria, M Gomes, AR Silva, ÂF Logullo, ...
The Breast 21 (3), 354-360, 2012
Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
S Ricardo, L Marcos-Silva, D Pereira, R Pinto, R Almeida, O Söderberg, ...
Molecular oncology 9 (2), 503-512, 2015
Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX 2 and CDX 2
V Camilo, M Garrido, P Valente, S Ricardo, AL Amaral, R Barros, ...
Histopathology 66 (3), 343-350, 2015
EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival
LS Monteiro, ML Delgado, S Ricardo, F Garcez, B Amaral, JJ Pacheco, ...
BioMed research international 2014, 2014
c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
S Carvalho, AO e Silva, F Milanezi, S Ricardo, D Leitão, I Amendoeira, ...
Journal of clinical pathology 57 (10), 1075-1079, 2004
Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma
LS Monteiro, ML Delgado, S Ricardo, F Garcez, B do Amaral, ...
Oral surgery, Oral medicine, Oral pathology and Oral radiology 115 (5), 638-645, 2013
Prognostic significance of CD44v6, p63, podoplanin and MMP‐9 in oral squamous cell carcinomas
LS Monteiro, ML Delgado, S Ricardo, B do Amaral, F Salazar, JJ Pacheco, ...
Oral Diseases 22 (4), 303-312, 2016
P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression
A Preto, JS Reis-Filho, S Ricardo, P Soares
Pathology-Research and Practice 198 (7), 449-454, 2002
Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes
F Schmitt, S Ricardo, AF Vieira, MR Dionísio, J Paredes
Virchows Archiv 460 (6), 545-553, 2012
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
R Coelho, L Marcos-Silva, S Ricardo, F Ponte, A Costa, JM Lopes, ...
Expert review of anticancer therapy 18 (2), 177-186, 2018
Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression
H Cohen‐Dvashi, N Ben‐Chetrit, R Russell, S Carvalho, M Lauriola, ...
EMBO molecular medicine 7 (3), 299-314, 2015
Claudin expression in breast cancer: high or low, what to expect?
S Ricardo, R Gerhard, JF Cameselle-Teijeiro, F Schmitt, J Paredes
F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de …, 2012
The system can't perform the operation now. Try again later.
Articles 1–20